Challenging Cases in Colposcopy and Cervical Cancer Screening

April 18
01:00 PM - 05:00 PM

This course will use challenging cases to help participants better manage patients within the frameworks of recent national recommendations published by ASCCP and other professional organizations.  These include the ASCCP/ACS/ASCP Screening Guidelines for the Prevention and Early Detection of Cervical Cancer, the ASCCP Guidelines for the Management of Abnormal Screening Tests and Cancer Precursors, the ASCCP/SGO Interim Guidance on the Clinical Use of Primary HPV Testing for Cervical Cancer Screening, and the ASCCP/CAP Lower Anogenital Squamous Terminology. The challenging cases presented and faculty discussion will not only help participants to understand how to use the various guidelines in common clinical situations, but will also explore acceptable management scenarios in situations for which the guidelines and algorithms may not apply.  While these five guidelines have been in clinical use for several years now, they are not without controversy. Some of the controversial aspects of these guidelines will be explored by the course faculty.  After attending this postgraduate course, attendees will have a better understanding of the rationale for the recommendations, and opportunities to apply these guidelines in various common, and uncommon, specific cases and patient populations.

Educational objectives

• Apply an understanding of the epidemiology and natural history of HPV and cervical cancer precursors to the rational screening of women for cervical cancer using the current consensus guidelines and interim guidance for use of primary HPV testing for cervical cancer screening.
• Apply the basic and clinical science underlying the Updated Consensus Management Guidelines to the individualized management of abnormal screening tests and pre-invasive histologic lesions.
• Manage women from special populations (e.g., adolescent, postmenopausal, and pregnant women) with abnormal screening results and CIN/AIS.
• Interpret biopsy results that use the LAST terminology LSIL/HSIL rather than CIN 1, CIN2, CIN3.

Course Level: Intermediate or Advanced

Course Director: Alan Waxman, MD, MPH

Speakers: Richard Guido, MD // Anna-Barbara Moscicki, MD